Clinical trials for the Russian Sputnik V vaccine will be held in India this month, the chief of the Russian Direct Investment Fund (RDIF) said in an interview.
Besides India, clinical trials will also begin this month in Saudi Arabia, UAE, the Philippines, and Brazil and the preliminary results of this phase (Phase 3) will be published in October-November.
The RDIF CEO denied Russia had stolen the vaccine and claimed Gamaleya Center had modified an existing platform developed in 2015 for Ebola fever, which went through all phases of clinical trials and was successfully used in Africa in 2017.
Prime Minister Boris Johnson’s government was reportedly planning new legislation to override parts of the Brexit Withdrawal Agreement it signed in January.
That could potentially jeopardise the whole treaty and create frictions in British-ruled Northern Ireland where special arrangements had been made to avoid a hard border with Ireland to the south that could be detrimental to a peace agreement.
Britain left the EU on January 31 but talks on a new trade deal before the end of a status-quo transition arrangement in December have snagged on state aid rules and fishing.